Vanda Pharmaceuticals Inc. (VNDA)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch VNDA
See up to 3 months of VNDA. The 7-day demo opens the 1M and 3M ranges and puts VNDA on your watchlist.
Start 7-day demoLatest VNDA insider trades
About Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. is an SEC registrant, filing under CIK 0001347178, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
VNDA Form 4 activity by transaction type, last 90 days
No Form 4 activity for VNDA in the last 90 days.
VNDA insider transactions (Form 4)
2323 Form 4 filings on record, the earliest from Nov 18, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daniel Patrick McGuire - Officer | Grant or award | Common Stock | 80,000 footnote F1 | $0.00 | - | |
| ||||||
 Phaedra Chrousos | Grant or award | Common Stock | 41,600 footnote F1 | $0.00 | - | |
| ||||||
| Charles Cliff Duncan | Grant or award | Common Stock | 41,600 footnote F1 | $0.00 | - | |
| ||||||
| Richard W. Dugan | Grant or award | Common Stock | 41,600 footnote F1 | $0.00 | - | |
| ||||||
| Anne Sempowski Ward | Grant or award | Common Stock | 41,600 footnote F1 | $0.00 | - | |
| ||||||
| Tage Honore | Grant or award | Common Stock | 41,600 footnote F1 | $0.00 | - | |
| ||||||
| Stephen Ray Mitchell | Grant or award | Common Stock | 41,600 footnote F1 | $0.00 | - | |
| ||||||
| Stephen Ray Mitchell | Gift | Common Stock | 25,836 | $0.00 | - | |
| Charles Cliff Duncan | Grant or award | Common Stock | 57,101 footnote F1 | $0.00 | - | |
| ||||||
| Timothy Williams - Officer | Open-market sale | Common Stock | 42,434 footnote F1 | $8.27 footnote F2 | $351K | |
| ||||||
| Kevin Patrick Moran - Officer | Open-market sale | Common Stock | 42,442 footnote F1 | $8.27 footnote F2 | $351K | |
| ||||||
| Joakim Wijkstrom - Officer | Open-market sale | Common Stock | 30,800 footnote F1 | $8.27 footnote F2 | $255K | |
| ||||||
| Mihael Hristos Polymeropoulos - Officer | Open-market sale | Common Stock | 156,235 footnote F1 | $8.17 footnote F2 | $1.28M | |
| ||||||
| Gunther Birznieks - Officer | Open-market sale | Common Stock | 42,431 footnote F1 | $8.27 footnote F2 | $351K | |
| ||||||
| Tage Honore | Open-market sale | Common Stock | 30,000 | $8.03 | $241K | |
| Joakim Wijkstrom - Officer | Grant or award | Common Stock | 125,000 footnote F1 | $0.00 | - | |
| ||||||
| Gunther Birznieks - Officer | Grant or award | Common Stock | 125,000 footnote F1 | $0.00 | - | |
| ||||||
| Timothy Williams - Officer | Grant or award | Common Stock | 125,000 footnote F1 | $0.00 | - | |
| ||||||
| Kevin Patrick Moran - Officer | Grant or award | Common Stock | 125,000 footnote F1 | $0.00 | - | |
| ||||||
| Mihael Hristos Polymeropoulos - Officer | Grant or award | Common Stock | 525,000 footnote F1 | $0.00 | - | |
| ||||||
| Mihael Hristos Polymeropoulos - Officer | Open-market purchase | Common Stock | 10,000 | $4.15 | $42K | |
| Richard W. Dugan | Grant or award | Common Stock | 59,225 | $0.00 | - | |
| Stephen Ray Mitchell | Open-market sale | Common Stock | 5,000 | $5.17 | $26K | |
Item 2.02, 9.01
Item 5.07
Item 2.02, 9.01
Item 5.02, 9.01
VNDA insider trading FAQ
What is the latest insider trade for VNDA?
Vanda Pharmaceuticals Inc. (VNDA) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-08. The full record for VNDA runs to 23 Form 4 filings, the earliest from 2024-11-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VNDA stock?
No insider purchases of VNDA were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling VNDA stock?
No insider sales of VNDA were filed in the last 90 days. 7 sales are on record for this company.
Where can I see VNDA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VNDA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Daniel Patrick McGuire view on EDGAR
- - Phaedra Chrousos view on EDGAR
- - Charles Cliff Duncan view on EDGAR
- - Richard W. Dugan view on EDGAR
- - Anne Sempowski Ward view on EDGAR
- - Tage Honore view on EDGAR
- - Stephen Ray Mitchell view on EDGAR
- - Stephen Ray Mitchell view on EDGAR
- - Charles Cliff Duncan view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where VNDA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VNDA with a 7-day demo
- VNDA on your watchlist
- Every VNDA Form 4 filing on record
- Up to 3 months of VNDA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
